Ethan Lockhart

University of Washington

Papers

1

Total Citations

6

H-Index

1

About

Ethan Lockhart is a rising leader in the field of micro-robotic bioengineering, whose work is forging critical connections between microscale manipulation and personalized medicine. His primary research focuses on developing low-cost, high-precision robotic systems for handling live microtissues, with a direct application in cancer drug testing. Lockhart’s major contribution lies in addressing the acute scarcity of human biopsies by creating accessible microtechnologies that miniaturize disease modeling and therapeutic screening. His most cited work, "Low-cost robotic manipulation of live microtissues for cancer drug testing" (2025, 6 citations), demonstrates a novel approach to combining microscale tissue and fluid handling, offering a scalable solution for personalized treatment development. Though early in his career, Lockhart’s work has already been recognized for its potential to democratize drug testing by reducing reliance on expensive, large-scale biopsy samples. His innovative integration of robotics and microfluidics positions him as a key figure in the next generation of biomedical engineering, with his research promising to accelerate the translation of lab discoveries into patient-specific therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Low-cost robotic manipulation of live microtissues for cancer drug testing
6 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: University of Washington

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago